Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
2022 · Blood · 2,785 citations
https://doi.org/10.1182/blood.2022016867
E
Eytan M. Stein
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
504
Papers
16.1K
Citations
49
h-index
155
i10-index
Eytan M. Stein is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 49, co-authored 429 publications.
ORCID: 0000-0001-8992-9390Papers by this author
worksEnasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
2017 · Blood · 1,419 citations
https://doi.org/10.1182/blood-2017-04-779405
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
2020 · The Lancet Haematology · 86 citations
https://doi.org/10.1016/s2352-3026(20)30205-2
Acute myeloid leukemia management and research in 2025
2024 · CA A Cancer Journal for Clinicians · 85 citations
https://doi.org/10.3322/caac.21873
Safety and Efficacy of AG-221, a Potent Inhibitor of Mutant IDH2 That Promotes Differentiation of Myeloid Cells in Patients with Advanced Hematologic Malignancies: Results of a Phase 1/2 Trial
2015 · Blood · 72 citations
https://doi.org/10.1182/blood.v126.23.323.323
Relapse after Allogeneic Stem Cell Transplantation of Acute Myelogenous Leukemia and Myelodysplastic Syndrome and the Importance of Second Cellular Therapy
2021 · Transplantation and Cellular Therapy · 40 citations
https://doi.org/10.1016/j.jtct.2021.05.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat